Companies › COLL

COLLEGIUM PHARMACEUTICAL INC COM (COLL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001267565 · EDGAR filings · Updated 2026-07-17

COLLEGIUM PHARMACEUTICAL INC COM (COLL) has reported institutional ownership of 116.2%, with 265 institutional managers holding positions valued at $1.25B per the latest 13F reporting period.

Latest updates

• 2026-07-17 — Notice of proposed sale filed (Form 144)
• 2026-07-15 — Notice of proposed sale filed (Form 144)
• 2026-06-30 — Amended current report (8-K/A) filed
• 2026-06-10 — Insider transaction reported (Form 4)
• 2026-06-01 — Employee-plan registration (S-8) filed
• 2026-06-01 — Employee-plan registration (S-8) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, COLLEGIUM PHARMACEUTICAL INC COM has 265 institutional holders and institutional ownership of 116.2%.

Insider activity

Insiders reported 50 transactions (0 buys, 17 sells) across 14 reporting insiders, with a net reported value of −$9.85M.

Related companies

BAUSCH HEALTH COS INC (BHC) · WAVE LIFE SCIENCES LTD (WVE) · VIR BIOTECHNOLOGY INC COM (VIR) · ALPHATEC HLDGS INCORPORATED COM NEW (ATEC) · TAYSHA GENE THERAPIES (TSHA) · U S PHYSICAL THERAPY (USPH)